E. Abramov, I. Dolev, H. Fogel, G. D. Ciccotosto, E. Ruff et al., Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses, Nat. Neurosci, vol.12, pp.1567-1576, 2009.

A. Aguirre, J. Blazquez-prieto, L. Amado-rodriguez, I. Lopez-alonso, E. Batalla-solis et al., Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia, J. Mol. Med, vol.95, pp.487-497, 2017.

M. Ahmad, T. Takino, H. Miyamori, T. Yoshizaki, M. Furukawa et al., Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases, J. Biochem, vol.139, pp.517-526, 2006.

M. Alvarez-fernandez, A. J. Barrett, B. Gerhartz, P. M. Dando, J. Ni et al., Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site, J. Biol. Chem, vol.274, pp.19195-19203, 1999.

J. R. Backstrom, G. P. Lim, M. J. Cullen, and Z. A. Tokes, Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide, pp.1-40, 1996.

, J. Neurosci, vol.16, pp.7910-7919

K. Baranger, A. E. Bonnet, S. D. Girard, J. M. Paumier, L. Garcia-gonzalez et al., MT5-MMP promotes Alzheimer's pathogenesis in the frontal cortex of 5xFAD mice and APP trafficking in vitro, Front. Mol. Neurosci, vol.9, p.163, 2017.

K. Baranger, P. Giannoni, S. D. Girard, S. Girot, F. Gaven et al., Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease, Neuropharmacology, vol.126, pp.128-141, 2017.

K. Baranger, M. Khrestchatisky, and S. Rivera, MT5-MMP, just a new APP processing proteinase in Alzheimer's disease?, J. Neuroinflammation, vol.13, p.167, 2016.

K. Baranger, Y. Marchalant, A. E. Bonnet, N. Crouzin, A. Carrete et al., MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease, Cell Mol. Life Sci, vol.73, pp.217-236, 2016.

K. Baranger, S. Rivera, F. D. Liechti, D. Grandgirard, J. Bigas et al., Endogenous and synthetic MMP inhibitors in CNS physiopathology, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01718187

. Prog, Brain Res, vol.214, pp.313-351

S. Barao, D. Moechars, S. F. Lichtenthaler, D. Strooper, and B. , BACE1 physiological functions may limit its use as therapeutic target for Alzheimer's disease, Trends Neurosci, vol.39, pp.158-169, 2016.

G. Basurto-islas, I. Grundke-iqbal, Y. C. Tung, F. Liu, and K. Iqbal, Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease, J. Biol. Chem, vol.288, pp.17495-17507, 2013.

G. Basurto-islas, J. H. Gu, Y. C. Tung, F. Liu, and K. Iqbal, Mechanism of Tau hyperphosphorylation involving lysosomal enzyme asparagine endopeptidase in a mouse model of brain ischemia, J. Alzheimers Dis, vol.63, pp.821-833, 2018.

C. Becker-pauly and C. U. Pietrzik, The metalloprotease meprin beta is an alternative beta-secretase of, APP. Front. Mol. Neurosci, vol.9, p.159, 2016.

I. Benilova, E. Karran, D. Strooper, and B. , The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes, Nat. Neurosci, vol.15, pp.349-357, 2012.

A. Beroun, S. Mitra, P. Michaluk, B. Pijet, M. Stefaniuk et al., MMPs in learning and memory and neuropsychiatric disorders, Cell Mol. Life. Sci, vol.76, pp.3207-3228, 2019.

E. Bertrand, E. Brouillet, I. Caille, C. Bouillot, G. M. Cole et al., A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo, Mol. Cell. Neurosci, vol.18, pp.503-511, 2001.

J. Bien, T. Jefferson, M. Causevic, T. Jumpertz, L. Munter et al., The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species, J. Biol. Chem, vol.287, pp.33304-33313, 2012.

A. Bourgeois, I. Lauritzen, T. Lorivel, C. Bauer, F. Checler et al., Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and spatial learning deficits in 3xTgAD and 2xTgAD mice, Neurobiol. Aging, vol.71, pp.21-31, 2018.

M. Brkic, S. Balusu, E. Van-wonterghem, N. Gorle, I. Benilova et al., Amyloid beta oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases, J. Neurosci, vol.35, pp.12766-12778, 2015.

H. Bukhari, A. Glotzbach, K. Kolbe, G. Leonhardt, C. Loosse et al., Small things matter: implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease, Prog. Neurobiol, vol.156, pp.189-213, 2017.

W. A. Campbell, M. L. Reed, J. Strahle, M. S. Wolfe, and W. Xia, Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from gamma-secretase, J. Neurochem, vol.85, pp.1563-1574, 2003.

J. M. Castellano, K. I. Mosher, R. J. Abbey, A. A. Mcbride, M. L. James et al., Human umbilical cord plasma proteins revitalize hippocampal function in aged mice, Nature, vol.544, pp.488-492, 2017.

A. H. Caster and R. A. Kahn, Recruitment of the Mint3 adaptor is necessary for export of the amyloid precursor protein (APP) from the Golgi complex, J. Biol. Chem, vol.288, pp.28567-28580, 2013.

K. A. Chang, H. J. Kim, and Y. H. Suh, The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout, Neurodegener. Dis, vol.10, pp.27-29, 2012.

K. A. Chang, H. S. Kim, T. Y. Ha, J. W. Ha, K. Y. Shin et al., Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration, Mol. Cell. Biol, vol.26, pp.4327-4338, 2006.

A. C. Chen, S. Kim, N. Shepardson, S. Patel, S. Hong et al., Physical and functional interaction between the alpha-and gamma-secretases: a new model of regulated intramembrane proteolysis, J. Cell Biol, vol.211, pp.1157-1176, 2015.

J. M. Chen, P. M. Dando, N. D. Rawlings, M. A. Brown, N. E. Young et al., Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase, J. Biol. Chem, vol.272, pp.8090-8098, 1997.

S. Chopra, C. M. Overall, and A. Dufour, Matrix metalloproteinases in the CNS: interferons get nervous, Cell Mol. Life Sci, vol.76, pp.3083-3095, 2019.

L. J. Chuo, W. H. Sheu, M. C. Pai, and Y. M. Kuo, Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease, Dement. Geriatr. Cogn. Disord, vol.23, pp.251-257, 2007.

E. N. Cline, M. A. Bicca, K. L. Viola, and W. L. Klein, The amyloidbeta oligomer hypothesis: beginning of the third decade, J. Alzheimers Dis, vol.64, 2018.

N. Crouzin, K. Baranger, M. Cavalier, Y. Marchalant, C. Cohen-solal et al., Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus, PLoS One, vol.8, p.74667, 2013.

B. De-strooper, Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process, Physiol. Rev, vol.90, pp.465-494, 2010.

B. De-strooper, C. Gutierrez, and L. , Learning by failing: ideas and concepts to tackle gamma-secretases in Alzheimer's disease and beyond, 2015.

, Annu. Rev. Pharmacol. Toxicol, vol.55, pp.419-437

S. Deb, J. Wenjun-zhang, and P. E. Gottschall, Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes, Brain Res, vol.970, pp.205-213, 2003.

S. S. Dominy, C. Lynch, F. Ermini, M. Benedyk, A. Marczyk et al., Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors, Sci. Adv, vol.5, p.3333, 2019.

F. H. Duits, M. Hernandez-guillamon, J. Montaner, J. D. Goos, A. Montanola et al., Matrix metalloproteinases in Alzheimer's disease and concurrent cerebral microbleeds, J. Alzheimers Dis, vol.48, pp.711-720, 2015.

S. Dusterhoft, U. Kunzel, F. , and M. , Rhomboid proteases in human disease: mechanisms and future prospects, Biochim. Biophys. Acta Mol. Cell Res, vol.1864, issue.11, pp.2200-2209, 2017.

G. P. Eckert, W. G. Wood, and W. E. Muller, Statins: drugs for Alzheimer's disease?, J. Neural Transm, vol.112, pp.1057-1071, 2005.

W. A. Eimer and R. Vassar, Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation, Mol. Neurodegener, vol.8, issue.2, 2013.

R. Fluhrer, G. Multhaup, A. Schlicksupp, M. Okochi, M. Takeda et al., Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation, J. Biol. Chem, vol.278, pp.5531-5538, 2003.

A. R. Folgueras, T. Valdes-sanchez, E. Llano, L. Menendez, A. Baamonde et al., Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.16451-16456, 2009.

L. K. Fong, M. M. Yang, R. Dos-santos-chaves, S. M. Reyna, V. F. Langness et al., Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-beta clearance in human astrocytes, J. Biol. Chem, vol.293, pp.11341-11357, 2018.

A. C. Fonseca, R. Resende, C. R. Oliveira, and C. M. Pereira, Cholesterol and statins in Alzheimer's disease: current controversies, Exp. Neurol, vol.223, pp.282-293, 2010.

B. G. Galvez, S. Matias-roman, J. P. Albar, F. Sanchez-madrid, and A. G. Arroyo, Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling, J. Biol. Chem, vol.276, pp.37491-37500, 2001.

T. C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar et al., Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.10032-10037, 2003.

M. S. Garcia-ayllon, I. Lopez-font, C. P. Boix, J. Fortea, R. Sanchez-valle et al., C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease, Sci. Rep, vol.7, p.2477, 2017.

D. Geroldi, P. Minoretti, M. Bianchi, C. Di-vito, M. Reino et al., Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians, Neurosci. Lett, vol.386, pp.176-178, 2005.

F. G. Gervais, D. Xu, G. S. Robertson, J. P. Vaillancourt, Y. Zhu et al., Involvement of caspases in proteolytic cleavage of Alzheimer's amyloidbeta precursor protein and amyloidogenic A beta peptide formation, Cell, vol.97, pp.395-406, 1999.

P. Giannoni, M. Arango-lievano, I. D. Neves, M. C. Rousset, K. Baranger et al., Cerebrovascular pathology during the progression of experimental Alzheimer's disease, Neurobiol. Dis, vol.88, pp.107-117, 2016.

S. D. Girard, K. Baranger, C. Gauthier, M. Jacquet, A. Bernard et al., Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease, J. Alzheimers Dis, vol.33, pp.781-796, 2013.

S. D. Girard, M. Jacquet, K. Baranger, M. Migliorati, G. Escoffier et al., Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease, Hippocampus, vol.24, pp.762-772, 2014.

Z. Gu, M. Kaul, B. Yan, S. J. Kridel, J. Cui et al., Snitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death, Science, vol.297, pp.1186-1190, 2002.

A. Haapasalo and D. M. Kovacs, The many substrates of presenilin/gamma-secretase, J. Alzheimers Dis, vol.25, pp.3-28, 2011.

C. Haass, C. Kaether, G. Thinakaran, and S. Sisodia, Trafficking and proteolytic processing of APP. Cold Spring Harb, Perspect. Med, vol.2, p.6270, 2012.

H. Hayashita-kinoh, H. Kinoh, A. Okada, K. Komori, Y. Itoh et al., Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth, Cell Growth Differ, vol.12, pp.573-580, 2001.

J. Hedrich, D. Lottaz, K. Meyer, I. Yiallouros, W. Jahnen-dechent et al., Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases, Biochemistry, vol.49, pp.8599-8607, 2010.

M. Hernandez-guillamon, P. Delgado, L. Ortega, M. Pares, A. Rosell et al., Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by betaamyloid 25-35 fragment, J. Neurosci. Res, vol.87, pp.2115-2125, 2009.

M. Hernandez-guillamon, S. Mawhirt, S. Blais, J. Montaner, T. A. Neubert et al., Sequential amyloid-beta degradation by the matrix metalloproteases MMP-2 and MMP-9, J. Biol. Chem, vol.290, pp.15078-15091, 2015.

M. Hernandez-guillamon, S. Mawhirt, S. Fossati, S. Blais, M. Pares et al., Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells, J. Biol. Chem, vol.285, pp.27144-27158, 2010.

M. Hick, U. Herrmann, S. W. Weyer, J. P. Mallm, J. A. Tschape et al., Acute function of secreted amyloid precursor protein fragment APPsalpha in synaptic plasticity, Acta Neuropathol, vol.129, pp.21-37, 2015.

S. Higashi and K. Miyazaki, Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity, J. Biol. Chem, vol.278, pp.14020-14028, 2003.

S. Higashi and K. Miyazaki, Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A, Biochemistry, vol.42, pp.6514-6526, 2003.

S. Higashi and K. Miyazaki, Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by betaamyloid precursor protein-derived inhibitor, J. Biol. Chem, vol.283, pp.10068-10078, 2008.

H. S. Hoe, M. J. Cooper, M. P. Burns, P. A. Lewis, M. Van-der-brug et al., The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis, J. Neurosci, vol.27, pp.10895-10905, 2007.

K. Holmbeck, P. Bianco, J. Caterina, S. Yamada, M. Kromer et al., MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover, Cell, vol.99, pp.81-92, 1999.

W. Hong, Z. Wang, W. Liu, T. T. O'malley, M. Jin et al., , 2018.

. Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer's disease brain, Acta Neuropathol, vol.136

J. T. Huse, K. Liu, D. S. Pijak, D. Carlin, V. M. Lee et al., Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain, J. Biol. Chem, vol.277, pp.16278-16284, 2002.

B. T. Hyman and J. Yuan, Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology, Nat. Rev. Neurosci, vol.13, pp.395-406, 2012.

Y. Itoh, Membrane-type matrix metalloproteinases: Their functions and regulations, Matrix Biol, pp.207-223, 2015.

S. Jawhar, A. Trawicka, C. Jenneckens, T. A. Bayer, and O. Wirths, Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease, Neurobiol. Aging, vol.33, 0196.

D. M. Jaworski, Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system, Brain Res, vol.860, pp.174-177, 2000.

T. Jefferson, M. Causevic, U. Keller, O. Schilling, S. Isbert et al., Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo, J. Biol. Chem, vol.286, pp.27741-27750, 2011.

G. Jin, F. Zhang, K. M. Chan, H. L. Xavier-wong, B. Liu et al., MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development, EMBO J, vol.30, pp.2281-2293, 2011.

E. Jorissen, J. Prox, C. Bernreuther, S. Weber, R. Schwanbeck et al., The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex, J. Neurosci, vol.30, pp.4833-4844, 2010.

J. Jourquin, E. Tremblay, N. Decanis, G. Charton, S. Hanessian et al., Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate, Eur. J. Neurosci, vol.18, pp.1507-1517, 2003.

S. A. Kaeser, M. C. Herzig, J. Coomaraswamy, E. Kilger, M. L. Selenica et al., Cystatin C modulates cerebral beta-amyloidosis, Nat. Genet, vol.39, pp.1437-1439, 2007.

D. Y. Kallop, W. J. Meilandt, A. Gogineni, C. Easley-neal, T. Wu et al., A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models, J. Neurosci, vol.34, pp.6425-6437, 2014.

K. Karmilin, C. Schmitz, M. Kuske, H. Korschgen, M. Olf et al., Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases, Sci. Rep, vol.9, p.546, 2019.

E. Karran, M. Mercken, D. Strooper, and B. , The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Nat. Rev. Drug Discov, vol.10, pp.698-712, 2011.

H. S. Kim, E. M. Kim, J. P. Lee, C. H. Park, S. Kim et al., C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression, FASEB J, vol.17, pp.1951-1953, 2003.

S. Kim, Y. Sato, P. S. Mohan, C. Peterhoff, A. Pensalfini et al., Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease, Mol. Psychiatry, vol.21, pp.707-716, 2016.

A. Kimura, S. Hata, and T. Suzuki, Alternative selection of betasite APP-cleaving enzyme 1 (BACE1) cleavage sites in amyloid beta-protein precursor (APP) harboring protective and pathogenic mutations within the abeta sequence, J. Biol. Chem, vol.291, pp.24041-24053, 2016.

R. Kimura, L. Devi, and M. Ohno, Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice, J. Neurochem, vol.113, pp.248-261, 2010.

A. Kojima, M. Konishi, A. , and T. , Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu(2)(+)-binding, Biomolecules, vol.4, pp.510-526, 2014.

K. Komori, T. Nonaka, A. Okada, H. Kinoh, H. Hayashita-kinoh et al., Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase, FEBS Lett, vol.557, pp.125-128, 2004.

P. H. Kuhn, K. Koroniak, S. Hogl, A. Colombo, U. Zeitschel et al., Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons, EMBO J, vol.31, pp.3157-3168, 2012.

P. H. Kuhn, H. Wang, B. Dislich, A. Colombo, U. Zeitschel et al., ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons, EMBO J, vol.29, pp.3020-3032, 2010.

S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. Pfeiffer et al., Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci. U.S.A, vol.96, pp.3922-3927, 1999.

A. Langenfurth, J. L. Rinnenthal, K. Vinnakota, V. Prinz, A. S. Carlo et al., Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases, J. Neurosci. Res, vol.92, pp.275-286, 2014.

K. Laulagnier, C. Javalet, F. J. Hemming, M. Chivet, G. Lachenal et al., Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons, Cell Mol. Life Sci, vol.75, pp.757-773, 2018.

I. Lauritzen, R. Pardossi-piquard, C. Bauer, E. Brigham, J. D. Abraham et al., The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in tripletransgenic mouse hippocampus, J. Neurosci, vol.32, pp.16243-11655, 2012.

I. Lauritzen, R. Pardossi-piquard, A. Bourgeois, S. Pagnotta, M. G. Biferi et al., Intraneuronal aggregation of the beta-CTF fragment of APP (C99) induces Abeta-independent lysosomal-autophagic pathology, Acta Neuropathol, vol.132, pp.257-276, 2016.

A. Leblanc, H. Liu, C. Goodyer, C. Bergeron, and J. Hammond, Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease, J. Biol. Chem, vol.274, pp.23426-23436, 1999.

M. C. Liao and W. E. Van-nostrand, Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro, Biochemistry, vol.49, pp.1127-1136, 2010.

F. Liebsch, L. Kulic, C. Teunissen, A. Shobo, I. Ulku et al., Abeta34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression, Nat. Commun, vol.10, p.2240, 2019.

K. Liu, R. W. Doms, and V. M. Lee, Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression, Biochemistry, vol.41, pp.3128-3136, 2002.

L. Liu, L. Ding, M. Rovere, M. S. Wolfe, and D. J. Selkoe, A cellular complex of BACE1 and gamma-secretase sequentially generates Abeta from its full-length precursor, J. Cell Biol, vol.218, pp.644-663, 2019.

E. Llano, A. M. Pendas, J. P. Freije, A. Nakano, V. Knauper et al., Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors, Cancer Res, vol.59, pp.2570-2576, 1999.

S. Lorenzl, D. S. Albers, P. A. Lewitt, J. W. Chirichigno, S. L. Hilgenberg et al., Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases, J. Neurol. Sci, vol.207, pp.71-76, 2003.

S. Lorenzl, D. S. Albers, N. Relkin, T. Ngyuen, S. L. Hilgenberg et al., Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease, Neurochem. Int, vol.43, pp.191-196, 2003.

D. C. Lu, S. Rabizadeh, S. Chandra, R. F. Shayya, L. M. Ellerby et al., A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor, Nat. Med, vol.6, pp.397-404, 2000.

N. N. Lunde, T. Bosnjak, R. Solberg, and H. T. Johansen, Mammalian legumain -A lysosomal cysteine protease with extracellular functions, Biochimie, 2019.

A. Madeira, J. M. Pommet, A. Prochiantz, A. , and B. , SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain, FASEB J, vol.19, pp.1905-1907, 2005.

C. L. Masters, R. Bateman, K. Blennow, C. C. Rowe, R. A. Sperling et al., Alzheimer's disease, Nat. Rev. Dis. Primers, vol.1, p.15056, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01723790

S. Matias-roman, B. G. Galvez, L. Genis, M. Yanez-mo, G. De-la-rosa et al., Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium, Blood, vol.105, pp.3956-3964, 2005.

Y. Matsumoto, S. Watanabe, Y. H. Suh, and T. Yamamoto, Effects of intrahippocampal CT105, a carboxyl terminal fragment of beta-amyloid precursor protein, alone/with inflammatory cytokines on working memory in rats, J. Neurochem, vol.82, pp.234-239, 2002.

M. P. Mattson, B. Cheng, A. R. Culwell, F. S. Esch, I. Lieberburg et al., Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein, Neuron, vol.10, pp.243-254, 1993.

W. Mi, M. Pawlik, M. Sastre, S. S. Jung, D. S. Radvinsky et al., Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models, Nat. Genet, vol.39, pp.1440-1442, 2007.

K. Miyazaki, M. Hasegawa, K. Funahashi, and M. Umeda, A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor, Nature, vol.362, pp.839-841, 1993.

B. G. Mockett, D. Guevremont, M. K. Elder, K. D. Parfitt, K. Peppercorn et al., Glutamate receptor trafficking and protein synthesis mediate the facilitation of ltp by secreted amyloid precursor protein-alpha, J Neurosci, vol.39, pp.3188-3203, 2019.

R. D. Moir, R. Lathe, and R. E. Tanzi, The antimicrobial protection hypothesis of Alzheimer's disease, Alzheimers Dement, vol.14, pp.1602-1614, 2018.

S. Monea, B. A. Jordan, S. Srivastava, S. Desouza, and E. B. Ziff, Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins, J. Neurosci, vol.26, pp.2300-2312, 2006.

E. Montagna, M. M. Dorostkar, and J. Herms, The role of APP in structural spine plasticity, Front. Mol. Neurosci, vol.10, p.136, 2017.

J. Montaner, L. Ramiro, A. Simats, M. Hernandez-guillamon, P. Delgado et al., Matrix metalloproteinases and ADAMs in stroke, Cell Mol. Life Sci, vol.76, pp.3117-3140, 2019.

J. E. Morley, S. A. Farr, W. A. Banks, S. N. Johnson, K. A. Yamada et al., A physiological role for amyloid-beta protein:enhancement of learning and memory, J. Alzheimers Dis, vol.19, pp.441-449, 2010.

B. Mroczko, M. Groblewska, M. Zboch, A. Kulczynska, O. M. Koper et al., Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease, J. Alzheimers Dis, vol.40, pp.351-357, 2014.

L. Mucke and D. J. Selkoe, Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb, Perspect. Med, vol.2, p.6338, 2012.

U. C. Muller, T. Deller, and M. Korte, Not just amyloid: physiological functions of the amyloid precursor protein family, Nat. Rev. Neurosci, vol.18, pp.281-298, 2017.

L. Muri, D. Leppert, D. Grandgirard, and S. L. Leib, MMPs and ADAMs in neurological infectious diseases and multiple sclerosis, Cell Mol. Life Sci, vol.76, pp.3097-3116, 2019.

N. N. Nalivaeva, C. Beckett, N. D. Belyaev, A. J. Turner, R. L. Neve et al., Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?, Neurobiol. Aging, vol.120, pp.191-203, 1996.

A. Nikolaev, T. Mclaughlin, D. D. O'leary, and M. Tessier-lavigne, APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, Nature, vol.457, pp.981-989, 2009.

H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao et al., Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J. Neurosci, vol.26, pp.10129-10140, 2006.

D. Obregon, H. Hou, J. Deng, B. Giunta, J. Tian et al., Soluble amyloid precursor protein-alpha modulates beta-secretase activity and amyloid-beta generation, Nat. Commun, vol.3, p.777, 2012.

C. Ogier, R. Creidy, J. Boucraut, P. D. Soloway, M. Khrestchatisky et al., Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study, BMC Neurosci, vol.6, p.68, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00092828

M. Ohno, Alzheimer's therapy targeting the beta-secretase enzyme BACE1: benefits and potential limitations from the perspective of animal model studies, Brain Res. Bull, vol.126, issue.2, pp.183-198, 2016.

M. Ohno, S. L. Cole, M. Yasvoina, J. Zhao, M. Citron et al., BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD, 2007.

. App/ps1-transgenic-mice, Neurobiol. Dis, vol.26, pp.134-145

E. Ohuchi, K. Imai, Y. Fujii, H. Sato, M. Seiki et al., Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules, J. Biol. Chem, vol.272, pp.2446-2451, 1997.

O. Olsen, D. Y. Kallop, T. Mclaughlin, S. Huntwork-rodriguez, Z. Wu et al., Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of beta-secretase, J. Neurosci, vol.34, pp.6438-6447, 2014.

M. L. Oster-granite, D. L. Mcphie, J. Greenan, and R. L. Neve, Agedependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein, J. Neurosci, vol.16, pp.6732-6741, 1996.

A. Ould-yahoui, O. Sbai, K. Baranger, A. Bernard, Y. Gueye et al., Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells, Cell Transplant, vol.22, pp.993-1010, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01460477

A. Ould-yahoui, E. Tremblay, O. Sbai, L. Ferhat, A. Bernard et al., A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons, PLoS One, vol.4, p.8289, 2009.

C. M. Overall, E. M. Tam, R. Kappelhoff, A. Connor, T. Ewart et al., Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors, Biol. Chem, vol.385, pp.493-504, 2004.

A. Pagenstecher, A. K. Stalder, C. L. Kincaid, S. D. Shapiro, and I. L. Campbell, Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states, Am. J. Pathol, vol.152, pp.729-741, 1998.

F. Panza, M. Lozupone, G. Logroscino, and B. P. Imbimbo, A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease, Nat Rev Neurol, vol.15, pp.73-88, 2019.

R. Pardossi-piquard and F. Checler, The physiology of the beta-amyloid precursor protein intracellular domain AICD, J. Neurochem, vol.120, pp.109-124, 2012.

S. Paschkowsky, M. Hamze, F. Oestereich, and L. M. Munter, Alternative processing of the amyloid precursor protein family by rhomboid protease RHBDL4, J. Biol. Chem, vol.291, pp.21903-21912, 2016.

S. Paschkowsky, J. M. Hsiao, J. C. Young, and L. M. Munter, The discovery of proteases and intramembrane proteolysis (1), Biochem. Cell Biol, vol.97, pp.265-269, 2019.

S. Paschkowsky, S. J. Recinto, J. C. Young, A. N. Bondar, and L. M. Munter, Membrane cholesterol as regulator of human rhomboid protease RHBDL4, J. Biol. Chem, vol.293, pp.15556-15568, 2018.

E. Pastrana, M. T. Moreno-flores, E. N. Gurzov, J. Avila, F. Wandosell et al., Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2, J. Neurosci, vol.26, pp.5347-5359, 2006.

J. M. Paumier, N. A. Py, L. Garcia-gonzalez, A. Bernard, D. Stephan et al., Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking, FASEB J, vol.33, pp.2910-2927, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02387988

D. Pei, Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP, J. Biol. Chem, vol.274, pp.8925-8932, 1999.

L. Pellegrini, B. J. Passer, M. Tabaton, J. K. Ganjei, and L. Adamio, , 1999.

, Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8, J. Biol. Chem, vol.274, pp.21011-21016

M. Pera, D. Alcolea, R. Sanchez-valle, C. Guardia-laguarta, M. Colom-cadena et al., Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease, Acta Neuropathol, vol.125, pp.201-213, 2013.

L. Perez-martinez and D. M. Jaworski, Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal, J. Neurosci, vol.25, pp.4917-4929, 2005.

C. Peters-libeu, J. Campagna, M. Mitsumori, K. S. Poksay, P. Spilman et al., sAbetaPPalpha is a Potent Endogenous Inhibitor of BACE1, J. Alzheimers Dis, vol.47, pp.545-555, 2015.

E. Porlan, B. Marti-prado, J. M. Morante-redolat, A. Consiglio, A. C. Delgado et al., MT5-MMP regulates adult neural stem cell functional quiescence through the cleavage of N-cadherin, Nat. Cell Biol, vol.16, pp.629-638, 2014.

R. Postina, A. Schroeder, I. Dewachter, J. Bohl, U. Schmitt et al., A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model, J. Clin. Invest, vol.113, pp.1456-1464, 2004.

M. Puchades, S. F. Hansson, C. L. Nilsson, N. Andreasen, K. Blennow et al., Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease, Brain Res. Mol. Brain Res, vol.118, pp.140-146, 2003.

M. Pulina, M. Hopkins, V. Haroutunian, P. Greengard, and V. Bustos, , 2019.

, C99, not beta-amyloid, is associated with selective death of vulnerable neurons in Alzheimer's disease

D. Puzzo, R. Piacentini, M. Fa, W. Gulisano, D. D. Li-puma et al., LTP and memory impairment caused by extracellular Abeta and Tau oligomers is APP-dependent, vol.6, p.26991, 2017.

D. Puzzo, L. Privitera, M. Fa, A. Staniszewski, G. Hashimoto et al., Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory, Ann. Neurol, vol.69, pp.819-830, 2011.

D. Puzzo, L. Privitera, E. Leznik, M. Fa, A. Staniszewski et al., Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus, J. Neurosci, vol.28, pp.14537-14545, 2008.

D. Puzzo, L. Privitera, and A. Palmeri, Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory, Neurobiol. Aging, vol.33, pp.15-1484, 1484.

N. A. Py, A. E. Bonnet, A. Bernard, Y. Marchalant, E. Charrat et al., Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Front, Aging Neurosci, vol.6, p.247, 2014.

L. Rajendran, A. , and W. , Membrane trafficking pathways in Alzheimer's disease, Traffic, vol.13, pp.759-770, 2012.

M. Rapti, S. J. Atkinson, M. H. Lee, A. Trim, M. Moss et al., The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition, Biochem. J, vol.411, pp.433-439, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00478897

S. Restituito, L. Khatri, I. Ninan, P. M. Mathews, X. Liu et al., Synaptic autoregulation by metalloproteases and gamma-secretase, 2011.

, J. Neurosci, vol.31, pp.12083-12093

H. C. Rice, D. De-malmazet, A. Schreurs, S. Frere, I. Van-molle et al., Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to modulate synaptic transmission, Science, vol.363, p.4827, 2019.

R. A. Rissman, W. W. Poon, M. Blurton-jones, S. Oddo, R. Torp et al., Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology, J. Clin. Invest, vol.114, pp.121-130, 2004.

S. Rivera, L. García-gonzález, M. Khrestchatisky, and K. Baranger, Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders, Cell Mol. Life Sci, vol.76, pp.3167-3191, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02387963

S. Rivera, M. Khrestchatisky, L. Kaczmarek, G. A. Rosenberg, and D. M. Jaworski, Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?, J. Neurosci, vol.30, pp.15337-15357, 2010.

S. Rivera, C. Ogier, J. Jourquin, S. Timsit, A. W. Szklarczyk et al., Gelatinase B and TIMP-1 are regulated in a cell-and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia, Eur. J. Neurosci, vol.15, pp.19-32, 2002.

S. Rivera, E. Tremblay, S. Timsit, O. Canals, Y. Ben-ari et al., Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response, J. Neurosci, vol.17, pp.4223-4235, 1997.

A. E. Roher, T. C. Kasunic, A. S. Woods, R. J. Cotter, M. J. Ball et al., Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A, Biochem. Biophys. Res. Commun, vol.205, pp.1755-1761, 1994.

C. Rose, E. Dorard, M. Audrain, L. Gorisse-hussonnois, N. Cartier et al., Transient increase in sAPPalpha secretion in response to Abeta1-42 oligomers: an attempt of neuronal self-defense?, Neurobiol. Aging, vol.61, pp.23-35, 2018.

T. Sakamoto and M. Seiki, Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity, Genes Cells, vol.14, pp.617-626, 2009.

R. Sannerud, C. Esselens, P. Ejsmont, R. Mattera, L. Rochin et al., Restricted location of PSEN2/gamma-secretase determines substrate specificity and generates an intracellular Abeta pool, Cell, vol.166, pp.193-208, 2016.

A. Saric, L. Brugge, D. Muller-pompalla, T. Rysiok, S. Ousson et al., Development and characterization of a novel membrane assay for full-length BACE-1 at pH 6.0, J. Biomol. Screen, vol.18, pp.277-285, 2013.

H. Sato, T. Takino, T. Kinoshita, K. Imai, Y. Okada et al., Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP), FEBS Lett, vol.385, pp.238-240, 1996.

F. Scharfenberg, F. Armbrust, L. Marengo, C. Pietrzik, and C. Becker-pauly, Regulation of the alternative beta-secretase meprin beta by ADAMmediated shedding, Cell Mol. Life Sci, vol.76, pp.3193-3206, 2019.

D. Schlenzig, H. Cynis, M. Hartlage-rubsamen, U. Zeitschel, K. Menge et al., Dipeptidyl-peptidase activity of meprin beta links N-truncation of Abeta with Glutaminyl Cyclase-Catalyzed pGlu-Abeta formation, J. Alzheimers Dis, vol.66, pp.359-375, 2018.

C. Schonherr, J. Bien, S. Isbert, R. Wichert, J. Prox et al., Generation of aggregation prone N-terminally truncated amyloid beta peptides by meprin beta depends on the sequence specificity at the cleavage site, Mol. Neurodegener, vol.11, p.19, 2016.

Y. Sekine-aizawa, E. Hama, K. Watanabe, S. Tsubuki, M. Kanai-azuma et al., Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum, Eur. J. Neurosci, vol.13, pp.935-948, 2001.

D. J. Selkoe and J. Hardy, The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol. Med, vol.8, pp.595-608, 2016.

X. P. Shi, K. Tugusheva, J. E. Bruce, A. Lucka, G. X. Wu et al., Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity, J. Biol. Chem, vol.278, pp.21286-21294, 2003.

M. Simons, B. De-strooper, G. Multhaup, P. J. Tienari, C. G. Dotti et al., Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons, J. Neurosci, vol.16, pp.899-908, 1996.

E. R. Smith, R. Nilforooshan, G. Weaving, and N. Tabet, Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease, J. Alzheimers Dis, vol.24, pp.327-333, 2011.

D. K. Song, M. H. Won, J. S. Jung, J. C. Lee, T. C. Kang et al., Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice, J. Neurochem, vol.71, pp.875-878, 1998.

S. Soriano, D. C. Lu, S. Chandra, C. U. Pietrzik, K. et al., The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases, J. Biol. Chem, vol.276, pp.29045-29050, 2001.

L. J. Sosa, A. Caceres, S. Dupraz, M. Oksdath, S. Quiroga et al., The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system, J. Neurochem, vol.143, pp.11-29, 2017.

S. J. Soscia, J. E. Kirby, K. J. Washicosky, S. M. Tucker, M. Ingelsson et al., The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide, PLoS One, vol.5, p.9505, 2010.

P. R. Spilman, V. Corset, O. Gorostiza, K. S. Poksay, V. Galvan et al., Netrin-1 interrupts amyloid-beta amplification, increases sabetappalpha in vitro and in vivo, and improves cognition in a mouse model of Alzheimer's disease, J. Alzheimers Dis, vol.52, pp.223-242, 2016.

A. E. Starr, A. Dufour, J. Maier, and C. M. Overall, Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16, J. Biol. Chem, vol.287, pp.5848-5860, 2012.

A. Y. Strongin, I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant et al., Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease, J. Biol. Chem, vol.270, pp.5331-5338, 1995.

J. Sun, J. Carlson-stevermer, U. Das, M. Shen, M. Delenclos et al., CRISPR/Cas9 editing of APP C-terminus attenuates beta-cleavage and promotes alpha-cleavage, Nat. Commun, vol.10, p.53, 2019.

E. M. Tam, C. J. Morrison, Y. I. Wu, M. S. Stack, and C. M. Overall, Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.6917-6922, 2004.

V. T. Tan, B. G. Mockett, S. M. Ohline, K. D. Parfitt, H. E. Wicky et al., Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease, Mol. Brain, vol.11, p.7, 2018.

M. Taniguchi, K. Matsuura, R. Nakamura, A. Kojima, M. Konishi et al., MMP-7 cleaves amyloid beta fragment peptides and copper ion inhibits the degradation, Biometals, vol.30, pp.797-807, 2017.

Y. Tian, C. J. Crump, and Y. M. Li, Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production, J. Biol. Chem, vol.285, pp.32549-32556, 2010.

A. Trivedi, L. J. Noble-haeusslein, J. M. Levine, A. D. Santucci, T. M. Reeves et al., Matrix metalloproteinase signals following neurotrauma are right on cue, Cell Mol. Life Sci, vol.76, pp.3141-3156, 2019.

T. Uekita, Y. Itoh, I. Yana, H. Ohno, and M. Seiki, Cytoplasmic taildependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity, J. Cell Biol, vol.155, pp.1345-1356, 2001.

Z. P. Van-acker, M. Bretou, A. , and W. , Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors, Mol. Neurodegener, vol.14, p.20, 2019.

C. Van-cauwenberghe, C. Van-broeckhoven, and K. Sleegers, The genetic landscape of Alzheimer disease: clinical implications and perspectives, Genet. Med, vol.18, pp.421-430, 2016.

R. Van-der-kant and L. S. Goldstein, Cellular functions of the amyloid precursor protein from development to dementia, Dev. Cell, vol.32, pp.502-515, 2015.

R. Vassar, B. D. Bennett, S. Babu-khan, S. Kahn, E. A. Mendiaz et al., Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, vol.286, pp.735-741, 1999.

R. Vassar, P. H. Kuhn, C. Haass, M. E. Kennedy, L. Rajendran et al., Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects, J. Neurochem, vol.130, pp.4-28, 2014.

J. P. Villa, G. P. Bertenshaw, J. E. Bylander, and J. S. Bond, Meprin proteolytic complexes at the cell surface and in extracellular spaces, Biochem. Soc. Symp, vol.70, pp.53-63, 2003.

T. Vogl, A. L. Gharibyan, and L. A. Morozova-roche, Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes, Int. J. Mol. Sci, vol.13, pp.2893-2917, 2012.

P. Wang, X. Wang, P. , and D. , Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV, J. Biol. Chem, vol.279, pp.20461-20470, 2004.

X. Wang, P. , and D. , Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation, J. Biol. Chem, vol.276, pp.35953-35960, 2001.

X. Wang, J. Yi, J. Lei, P. , and D. , Expression, purification and characterization of recombinant mouse MT5-MMP protein products, FEBS Lett, vol.462, pp.261-266, 1999.

X. Wang, X. Zhou, G. Li, Y. Zhang, Y. Wu et al., Modifications and trafficking of app in the pathogenesis of Alzheimer's disease, Front. Mol. Neurosci, vol.10, p.294, 2017.

Z. Wang, R. J. Jackson, W. Hong, W. M. Taylor, G. T. Corbett et al., Human brain-derived Abeta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP, J. Neurosci, vol.37, pp.11947-11966, 2017.

K. M. Warren, T. M. Reeves, and L. L. Phillips, MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury, J. Neurotrauma, vol.29, pp.1922-1940, 2012.

A. Weidemann, K. Paliga, U. Durrwang, F. B. Reinhard, O. Schuckert et al., Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases, J. Biol. Chem, vol.274, pp.5823-5829, 1999.

A. R. White, T. Du, K. M. Laughton, I. Volitakis, R. A. Sharples et al., Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity, J. Biol. Chem, vol.281, pp.17670-17680, 2006.

K. Wild, A. August, C. U. Pietrzik, and S. Kins, Structure and synaptic function of metal binding to the amyloid precursor protein and its proteolytic fragments, Front. Mol. Neurosci, vol.10, p.21, 2017.

M. Willem, S. Tahirovic, M. A. Busche, S. V. Ovsepian, M. Chafai et al., eta-Secretase processing of APP inhibits neuronal activity in the hippocampus, Nature, vol.526, pp.443-447, 2015.

L. Wojcik, A. Sawicka, S. Rivera, and T. Zalewska, Neurogenesis in gerbil hippocampus following brain ischemia: focus on the involvement of metalloproteinases, Acta Neurobiol. Exp, vol.69, pp.52-61, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417424

W. G. Wood, L. Li, W. E. Muller, and G. P. Eckert, Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis, J. Neurochem, vol.129, pp.559-572, 2014.

P. Yan, X. Hu, H. Song, K. Yin, R. J. Bateman et al., Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ, J. Biol. Chem, vol.281, pp.24566-24574, 2006.

R. Yan, Physiological functions of the beta-site amyloid precursor protein cleaving enzyme 1 and 2, Front. Mol. Neurosci, vol.10, p.97, 2017.

K. J. Yin, J. R. Cirrito, P. Yan, X. Hu, Q. Xiao et al., Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism, J. Neurosci, vol.26, pp.10939-10948, 2006.

Z. Zhang, O. Obianyo, E. Dall, Y. Du, H. Fu et al., Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease, Nat. Commun, vol.8, p.14740, 2017.

Z. Zhang, M. Song, X. Liu, S. S. Kang, I. S. Kwon et al., Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease, Nat. Med, vol.20, pp.1254-1262, 2014.

Z. Zhang, M. Song, X. Liu, S. Su-kang, D. M. Duong et al., Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease, Nat. Commun, vol.6, p.8762, 2015.

L. Zhou, S. Barao, M. Laga, K. Bockstael, M. Borgers et al., The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo, J. Biol. Chem, vol.287, pp.25927-25940, 2012.